BioNxt Solutions Inc.
XPHYF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$35.38M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $35.38 Million |
|---|---|
| Enterprise Value | $40.87 Million |
| Earnings per Share | $- |
| Beta | 0 |
| Outstanding Shares | - |
Return
| Return on Equity | 146.16% |
|---|---|
| Return on Assets | -591.08% |
| Return on Invested Capital | 160.69% |
Valuation & Multiples
| P/E Ratio | -3.52 |
|---|---|
| PEG | 29.49 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -4.96 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | -1.07 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BioNxt Solutions Inc.
25 employees
CEO: Hugh A. D. Rogers
Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017, operates as a bioscience company across Germany, Switzerland, Austria, Israel, and its home country. The firm focuses on developing innovative drug delivery ...